From 96cbedbf77682acb98d6df72f977e71adf3ddd7d Mon Sep 17 00:00:00 2001
From: Kisa <kisasttil@gmail.com>
Date: Mon, 22 Jun 2026 08:36:01 -0400
Subject: [PATCH] =?UTF-8?q?docs:=20correct=20Shield=20positioning=20?=
 =?UTF-8?q?=E2=80=94=20standalone=20compliance,=20not=20DMEPOS-specific?=
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit

---
 CLAUDE.md | 2 +-
 1 file changed, 1 insertion(+), 1 deletion(-)

diff --git a/CLAUDE.md b/CLAUDE.md
index fe7ad8e..54bbfd8 100644
--- a/CLAUDE.md
+++ b/CLAUDE.md
@@ -19,7 +19,7 @@ implying Signal contacts prescribers or patients directly.
 
 - LabABLE Meeting Fri 2026-06-26 1:30 PM — /pilot-prep (deferred).
 - Build Spec Phase 2 + Phase 4: Claude Code to build. Pi verifies after.
-- Shield competitor: Dash ComplyOps ($250/mo, horizontal compliance). Shield differentiator = DMEPOS vertical expertise. Insight planted in TriLane.
+- Shield competitor: Dash ComplyOps ($250/mo, horizontal compliance). Shield is standalone compliance product (not DMEPOS-specific). Differentiator: simplicity + optional Signal bundling for DMEPOS suppliers. Insight corrected in TriLane.
 - 3 validation product blockers: MA misclassification, duplicate patient_id, doc-status override (Claude Code on these).
 - Primary domain sttilsolutions.com still "Pending" in Clerk (non-blocking for auth).
 - Primary domain sttilsolutions.com still "Pending" in Clerk (non-blocking for auth).